Human CCL15/MIP-1 delta Antibody, R&D Systems™

Goat Polyclonal Antibody

Supplier:  R&D Systems AF628SP

Catalog No. AF628SP

Description

CCL15/MIP-1 delta Polyclonal specifically detects CCL15/MIP-1 delta in Human samples. It is validated for Western Blot, Neutralization.

Specifications

• Antigen: CCL15/MIP-1 delta
• Classification: Polyclonal
• Conjugate: Unconjugated
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
• Gene Alias: chemokine (C-C motif) ligand 15, Chemokine CC-2, HCC-2, HCC-2Lkn-1, leukotactin 1, Leukotactin-1, LKN1, LKN-1, Macrophage inflammatory protein 5, MIP1 delta, MIP-1 delta, MIP5, MIP-5, MIP-5MIP-1d, Mrp-2b, NCC-3, NCC-3MIP-1D, NCC3MRP-2B, new CC chemokine 3, SCYA15member 15, Small-inducible cytokine A15
• Host Species: Goat
• Purification Method: Affinity Purified
• Regulatory Status: RUO
• Gene ID (Entrez): 6359
• Reconstitution: Reconstitute at 0.2 mg/mL in sterile PBS.
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

• Applications: Western Blot, Neutralization
• Concentration: LYOPH
• Dilution: Western Blot 0.1 ug/mL, Neutralization 0.5-2.5 ug/mL
• Gene Accession No.: Q16663
• Gene Symbols: CCL15
• Immunogen: E. coli-derived recombinant human CCL15/MIP-1 delta Ser46-Ile113 Accession # Q16663
• Quantity: 25 μg
• Primary or Secondary: Primary
• Test Specificity: Detects human CCL15/MIP-1 delta in direct ELISAs and Western blots. In direct ELISAs and Western blots, a preference for the 68 aa residue isoform over the 92 aa residue isoform of human CCL15/LKN-1 is shown. Additionally, in direct ELISAs, less than 1% cross-reactivity with with rh6Ckine, rhBLC/BCA1, rhENA78, rhEotaxin, rhEotaxin2, rhFractalkine, rhGCP2, rhGRO alpha , rhGRO beta , rhGRO gamma , rhHCC1, rhHCC4, rhI309,rhIL8, rhMCP1, rhMCP2, rhMCP3, rhMCP4, rhMDC, rhMIG, rhMIP1 alpha , rhMIP1 beta , rhMIP3 alpha , rhMIP3 beta , rhMPIF1, rhNAP2, rhPARC, rhRANTES, rhSDF1 alpha ,rhSDF1 beta ,rhTarc, rhTECK, and rhVIC is observed. Neutralizes the biological activity of the 68 aa isoform of recombinant human (rh) CCL15/LKN-1. It will also neutralize the biological activity of the 92 aa residue isoform of rhCCL15/LKN-1 using a 2-fold higher Ig concentration.
• Target Species: Human
• Isotype: IgG

For Research Use Only